Wockhardt Ltd
-
{
- All
- News
-
Wockhardt Approaches Shareholders To Raise Up To Rs 1,200 Crore
Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Wockhardt Shares Gain on Unit Merger Plan
Traders cited Wockhardt's plans to merge two units with itself. The proposed consolidation will boost revenues and is good in the long term, traders said.
-
Wockhardt Q1 Net Profit Plunges 94% on Plant Bans
Generic drugmaker Wockhardt Ltd on Tuesday said its quarterly net profit plunged 94 per cent, as U.S. Food and Drug Administration bans on its manufacturing plants continued to take a toll.
-
Wockhardt Says US Drug Regulator Raises Concern Over US Unit
The FDA last year banned Wockhardt's two Indian units from exporting to the United States, its biggest market, citing quality lapses in the manufacturing process.
-
Zydus Cadila Recalls Over 10,000 Bottles of Allergy Drug In US
Promethazine hydrochloride is commonly used to treat allergic disorders, nausea, vomiting and difficulty sleeping, as well as for pre-operative sedation.
-
FDA Criticises Quality Control, Training at Wockhardt US Plant
Wockhardt's managing director Murtaza Khorakiwala said last week that FDA had expressed concerns over production processes at the US unit. He said the company had responded to the observations but declined to give details.
-
Wockhardt's Ex-Executive Barred From Securities Market For 6-Months For Insider Trading
Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge losses of over Rs 14 lakh averted by flouting insider trading rules.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Wockhardt Surges 5% As US Drug Regulator Excludes Drug From Import Alert
Shares of Wockhardt Ltd jumped as much as 4.75 per cent to hit intraday high of Rs 937 after the US drug regulator excluded one of its drugs from import alert it had issued to the company in August.
-
Expanding Markets, Launching New Products For Growth: Wockhardt
Wockhardt Ltd has said it is increasing investments in R&D, looking at expanding markets and launching new products to accelerate growth.
-
Wockhardt Approaches Shareholders To Raise Up To Rs 1,200 Crore
Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.
-
Cabinet To Decide On Axis Bank Rs 12,973 Crore Foreign Investment Proposal
The Cabinet Committee on Economic Affairs will take a final call on Axis Bank's Rs 12,973-crore foreign investment proposal, the Finance Ministry said on Wednesday.
-
Finance Ministry Looks To Expedite Clearances To FDI Proposals
Stressing that fast clearances and automatic process are key to recent surge in FDI inflows, Economic Affairs Secretary Shaktikanta Das on Thursday said all FDI applications received up to March 15 are listed in agenda for the next meeting of Foreign Investment Promotion Board (FIPB).
-
Wockhardt Posts Over 82% Fall in Q3 Profit
Pharmaceuticals major WockhardtLtd on Thursday reported an 82.44 per cent decline in consolidatednet profit at Rs 60.97 crore for the fiscal third quarter that ended onDecember 31, 2015.
-
Wockhardt Approaches Shareholders To Raise Up To Rs 1,200 Crore
Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Wockhardt Shares Gain on Unit Merger Plan
Traders cited Wockhardt's plans to merge two units with itself. The proposed consolidation will boost revenues and is good in the long term, traders said.
-
Wockhardt Q1 Net Profit Plunges 94% on Plant Bans
Generic drugmaker Wockhardt Ltd on Tuesday said its quarterly net profit plunged 94 per cent, as U.S. Food and Drug Administration bans on its manufacturing plants continued to take a toll.
-
Wockhardt Says US Drug Regulator Raises Concern Over US Unit
The FDA last year banned Wockhardt's two Indian units from exporting to the United States, its biggest market, citing quality lapses in the manufacturing process.
-
Zydus Cadila Recalls Over 10,000 Bottles of Allergy Drug In US
Promethazine hydrochloride is commonly used to treat allergic disorders, nausea, vomiting and difficulty sleeping, as well as for pre-operative sedation.
-
FDA Criticises Quality Control, Training at Wockhardt US Plant
Wockhardt's managing director Murtaza Khorakiwala said last week that FDA had expressed concerns over production processes at the US unit. He said the company had responded to the observations but declined to give details.
-
Wockhardt's Ex-Executive Barred From Securities Market For 6-Months For Insider Trading
Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge losses of over Rs 14 lakh averted by flouting insider trading rules.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Wockhardt Surges 5% As US Drug Regulator Excludes Drug From Import Alert
Shares of Wockhardt Ltd jumped as much as 4.75 per cent to hit intraday high of Rs 937 after the US drug regulator excluded one of its drugs from import alert it had issued to the company in August.
-
Expanding Markets, Launching New Products For Growth: Wockhardt
Wockhardt Ltd has said it is increasing investments in R&D, looking at expanding markets and launching new products to accelerate growth.
-
Wockhardt Approaches Shareholders To Raise Up To Rs 1,200 Crore
Wockhardt said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes.
-
Cabinet To Decide On Axis Bank Rs 12,973 Crore Foreign Investment Proposal
The Cabinet Committee on Economic Affairs will take a final call on Axis Bank's Rs 12,973-crore foreign investment proposal, the Finance Ministry said on Wednesday.
-
Finance Ministry Looks To Expedite Clearances To FDI Proposals
Stressing that fast clearances and automatic process are key to recent surge in FDI inflows, Economic Affairs Secretary Shaktikanta Das on Thursday said all FDI applications received up to March 15 are listed in agenda for the next meeting of Foreign Investment Promotion Board (FIPB).
-
Wockhardt Posts Over 82% Fall in Q3 Profit
Pharmaceuticals major WockhardtLtd on Thursday reported an 82.44 per cent decline in consolidatednet profit at Rs 60.97 crore for the fiscal third quarter that ended onDecember 31, 2015.
